Success Metrics

Clinical Success Rate
97.6%

Based on 81 completed trials

Completion Rate
98%(81/83)
Active Trials
5(5%)
Results Posted
41%(33 trials)
Terminated
2(2%)

Phase Distribution

Ph phase_3
13
12%
Ph not_applicable
27
25%
Ph phase_4
46
42%
Ph phase_2
13
12%
Ph phase_1
4
4%
Ph early_phase_1
1
1%

Phase Distribution

5

Early Stage

13

Mid Stage

59

Late Stage

Phase Distribution104 total trials
Early Phase 1First-in-human
1(1.0%)
Phase 1Safety & dosage
4(3.8%)
Phase 2Efficacy & side effects
13(12.5%)
Phase 3Large-scale testing
13(12.5%)
Phase 4Post-market surveillance
46(44.2%)
N/ANon-phased studies
27(26.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.3%

81 of 85 finished

Non-Completion Rate

4.7%

4 ended early

Currently Active

5

trials recruiting

Total Trials

109

all time

Status Distribution
Active(9)
Completed(81)
Terminated(4)
Other(15)

Detailed Status

Completed81
unknown15
Recruiting5
Not yet recruiting3
Terminated2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
109
Active
5
Success Rate
97.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.0%)
Phase 14 (3.8%)
Phase 213 (12.5%)
Phase 313 (12.5%)
Phase 446 (44.2%)
N/A27 (26.0%)

Trials by Status

terminated22%
recruiting55%
unknown1514%
enrolling_by_invitation11%
not_yet_recruiting33%
completed8174%
withdrawn22%

Recent Activity

Clinical Trials (109)

Showing 20 of 109 trialsScroll for more
NCT05887375Phase 4

Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery

Completed
NCT07524959Not Applicable

Antagonism of Neostigmine in Continuous Infusion of Mivacurium

Not Yet Recruiting
NCT06513013Phase 2

MgSO4 as Adjuvants to Bupivacaine vs Neostigmine in TAP Block in Cesarean Section

Completed
NCT07309393Not Applicable

Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary Function

Recruiting
NCT05116930Phase 2

Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture

Recruiting
NCT07203287Phase 4

Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease

Recruiting
NCT03111121Phase 4

Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy

Completed
NCT03923556Phase 4

Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery

Completed
NCT06982092Phase 1

Using Diaphragm Ultrasonography, Sugammadex Recovers Diaphragmatic Function More Effectively Than Neostigmine.

Completed
NCT03519633Phase 2

Role of Curarization During Anesthesia for Laparoscopic Hysterectomy

Completed
NCT05724550Not Applicable

Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in Children

Completed
NCT06436768Not Applicable

Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis

Completed
NCT06275542Not Applicable

Ability to Maintain Saturation Levels Without Oxygen Supplementation as a Extubation Criteria Without TOF Monitoring Equipment

Enrolling By Invitation
NCT03679611Phase 4

Impact of Sugammadex vs. Neostigmine Reversal on Post-Operative Recovery and Complications

Completed
NCT06334562Not Applicable

The Clinical Effect of Sugammadex Sodium (Domestic) for Antagonizing Neuromuscular Blockade After Thoracic Surgery

Recruiting
NCT06729047Phase 1

Prophylactic Intravenous Injection of Neostigmine Plus Atropine Versus Ketorolac on Post-dural Puncture Headache in Patients Undergoing Infraumbilical Surgeries

Not Yet Recruiting
NCT06687187

Effect of Two Different Doses of Neostigmine on the Gastric Residual Volume and Aspiration in Critically Ill Patients

Completed
NCT06678451Not Applicable

Sugammadex on Laparoscopic Bariatric Surgery

Not Yet Recruiting
NCT05794503Phase 4

Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex

Completed
NCT05354466Phase 4

Perioperative Respiratory Adverse events_sugammadex

Completed

Drug Details

Intervention Type
DRUG
Total Trials
109